Abstract
The one generally accepted definition of diabetes mellitus is hyperglycemia inappropriate to the existing environmental and nutritional state. However, this symptom is only one of many endocrine and metabolic alterations present inclinically overtdiabetes, among which disturbances in lipid metabolism are most important. Perhaps the oldest notion of the associated appearance of diabetes mellitus and hyperlipemia is, according to a quotation by Eggstein, a statement of Marietin 1799 (22), and in 1917 Joslin (18) stated: “with an excess of fat diabetes begins and from anexcess of fat diabetics die.” In the earlier part of this century most authors apparently agreed that the extent of hyperlipemia depended largely on the severity of active diabetic symptoms and that the blood-lipid concentration represented the most reliable prognostic criterion for the diabetic patient (6,18). This was contradicted, however, by several authors and in Germany among others by Katsch (19), who in 1938 expressed the view that the extent of disturbance of lipid metabolism was not generally related to the severity of diabetes, although in the mean blood lipids tended to rise with acute diabetic decompensation and to fall again with recompensation. The moderately to strongly elevated blood-lipid concentration in well-adjusted diabetics was judged by him torepresent a personal characteristic of the individual patient. Katsch and Krainick (19) already distinguished the reversible hyperlipemia accompanying the acute diabetic decompensation from the irreversible, permanent hyperlipemia of well-adjusted diabetics. In 1955 Adlersberg and Wang (1) delineated the combined appearance of mild diabetes mellitus and severe idiopathic hyperlipemia as a distinct syndrome, which has previously been noted by Thannhauser (36) and therefore is referred to by some as the Thannhauser-Adlersberg or Adlersberg-Wang syndrome and by others as the “diabetic-hyperlipemic syndrome”(23).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adlersberg, D., Wang, C.: Syndrome of idiopathic hyperlipemia, mild diabetes mellitus, and severe vascular damage. Diabetes 4, 210 (1955)
Adlersberg, D., Eisler, L.: Circulating lipids in diabetes mellitus. JAMA 170, 1261 (1959)
Albrink, M.J., Lavietes, P.H., Man, E.B.: Vascular disease and serum lipids in diabetes mellitus. Observations over 30 years (1931-1961). Ann. Int. Med. 58, 305 (1963)
Bergqvist, N.: Serum lipids in an ambulatory diabetic clientele. Acta med. scand. 187, 213 (1970)
Bierman, E.L., Porte, D.: Carbohydrate intolerance and lipemia. Ann. Int. Med. 68, 926 (1968)
Bloor, W.R.: The lipoids (“fat”) of the blood in diabetes. Journ. Biol. Chem. 26, 417 (1916)
Borrie, P., Slack, J.: A clinical syndrome characteristic of primary type IV-V hyperlipoproteinemia. Brit. Journ. Dermatology 90, 245 (1974)
Braunsteiner, H., Sailer, S., Sandhofer, F.: Plasmalipide bei Patiefoten mit Diabetes mellitus. Klin. Wschr. 44, 116 (1966)
Brown, D.F., Daudiss, K.: Hyperlipoproteinemia. Prevalence in a free-living population in Albany, New York. Circulation XLVII, 558 (1973)
Chance, G.W., Albutt, E.C., Edkins, S.M.: Serum lipids and lipoproteins in untreated diabetic children. Lancet I, 1126 (1969)
Eaton, R.P., Schade, D.S.: Glucagon resistance as a hormonal basis for endogenous hyperlipemia. Lancet I, 973 (1973)
Ford, S., Bozian, R.C., Knowles, H.C.: Interactions of obesity, and glucose and insulin levels in hypertriglyceridemia. Amer. Journ. Clin. Invest. 21, 904 (1968)
Glueck, C.J., Levy, R.I., Fredrickson, D.S.: Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, II, IV, and V hyperlipo-proteinemia. Diabetes 18, 739 (1969)
Gries, F.A., Engelhardt, A., Cramer, M., Jahnke, K.: Metabolite des Fett-und Kohlenhydratstoffwechsels bei normgewichtigen Stoffwechselgesunden sowie bei Adipösen und Diabetikern. Verhandl. Deutsch. Ges. Inn. Med. 76, 371 (1970)
Fredrickson, D.S., Levy, R.: Familial hyperlipoproteinemia. In: The Metabolic Basis of Inherited Disease, 3rd ed. Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S. (eds.). New York: McGraw Hill, 1972
Jacobsen, B.B.: Type Vhyperlipoproteinemia. Atherosclerosis 17, 471 (1973)
Jahnke, K.: Störungen des Fettstoffwechsels. Ärztl. Praxis 26,4438 (1974)
Joslin, E.P., Bloor, W.R., Gray, H.: The blood lipoids in diabetes. Journ. Amer. Med. Ass. 69, 375 (1917)
Katsch, G., Krainick, H.G.: Zur Physiologie und Pathologie des intermediären Fettstoffwechsels. Klin. Wschr. 18, 436 (1939)
Levy, R.I., Glueck, C.J.: Hypertriglyceridemia, diabetes mellitus, and coronary vessel disease. Arch. Intern. Med., 123, 220 (1969)
Man, E.B., Albrink, M.J.: Serum lipids in different phases of carbohydrate metabolism. Yale J. Biol. Med. 29, 316 (1956)
Mariet (1799). Cited by M. Eggstein: Diabetes und Fett. Med. Welt 18, 843 (1967)
Nikkilä, E.A.: Plasma triglycerides in human diabetes. Proc. Royal Soc. Med. 67, 662 (1974)
Nikkila, E.A.: Control of plasma and liver triglyceride kinetics by carbohydrate metabolism and insulin. Advances Lipid. Res. 7, 63 (1969)
Olefsky, J.M., Farquhar, J.W., Reaven, G.M.: Reappraisal of the role of insulin in hypertriglyceridemia. Amer. Journ. Med. 57, 551 (1974)
Reaven, G.M., Lerner, R.L., Stern, M.P., Farquhar, J.W., Nakanishi, R.: Role of insulin in endogenous hypertriglyceridemia. Journ. Clin. Invest. 46, 1756 (1967)
Reimer, F., Kremer, G.J., Müller, D.: Häufigkeit von Fettstoffwechselstörungen bei asymptomatischen und manifesten Diabetikern. Klin. Wschr. 51, 973 (1973)
Rose, H.G., Kranz, P., Weinstock, M., Juliano, J., Haft, J.I.: Combined hyperlipoproteinemia. Evidence for a new lipoprotein phenotype. Atherosclerosis 20, 51 (1974)
Righetti, A., Scherrer, J.R., Micheli, H., Pometta, D.: Etude clinique des relations entre lediabète, les hyperlipoprotéinémies et l’athéromatose. Schweiz. med. Wschr. 103, 668 (1973)
Saddi, R., Feingold, J.: Idiopathic hemochromatosis and diabetes mellitus. Clin. Genet. 5., 242 (1974)
Sailer, S., Bolzano, K., Sandhofer, F., Spath, P., Braunsteiner, H.: Triglyceridspiegel und Insulinkonzentration im Plasma nach oraler Glukosegabe bei Patienten mit primärer kohlenhydratinduzierter Hypertriglyceridamie. Schweiz. Med. Wschr. 98, 1512 (1968)
Santen, R.J., Willis, P.W., Fajans, S.S.: Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin level. Arch. Intern. Med. 130, 833 (1972)
Schlierf, G., Weinans, G., Weinans, T., Reinheimer, W., Kahlke, W.: Häufigkeit und Typenverteilung von Hyperlipoproteinämien bei stationären Patienten einer Medizinischen Klinik. Dtsch. Med. Wschr. 97, 1371 (1972)
Schonfeld, G., Kudzma, D.J.: Type IV hyperlipoproteinemia, acritical appraisal. Arch. Intern. Med. 132, 55 (1973)
Schonfeld, G., Birge, C., Miller, P., Kessler, G., Santiago, J.: Apolipoprotein B levels and altered lipoprotein composition in diabetes. Diabetes 23, 827 (1974)
Thannhauser, S.J.: lew Engl. J. Med. 237, 515 (1947). Cited by Nikkilä, 1974
Tiengo, A., Muggeo, M., Fedele, D., Marchior, E., Crepaldi, G.: Insulin-secretion in hyperlipoproteinemias. Act. Diabet. 11, 149 (1974)
Tzagournis, M., Chiles, R., Ryan, J.M., Skillman, T.G.: Interrelatioships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease. Circulation 38, 1156 (1968)
Vogelberg, K.H., Gries, F.A.: Hyperlipoproteinamie bei Diabetes Mellitus. Münchn. Med. Wschr. 115, 650 (1973)
Wahl, P., Hasslacher, Ch., Vollmar, J.: Diabetes und Hyperlipoproteinämien. Dtsch. Med. Wschr. 99, 2158 (1974)
Wille, L.E., Aarseth, S.: Demonstration of hyper-x-lipoproteinemia in three diabetic patients. Clin. Genet. 4, 281(1973)
Wilson, D.E., Schreibman, P.H., Day, V.C., Arky, R.A.: Hyperlipidemia in an adult diabetic population. J. Chron. Dis. 23, 501 (1970)
Wood, P.D.S., Stern, M.P., Silvers, A., Reaven, G.M., Groeben, J. von der: Prevalence of plasma lipoprotein abnormalities in a free-living population of the Central valley, California. Circulation XLV, 114 (1972)
Wollenweber, J., Christl, H.L., Schlierf, Chr., Wohlenberg, H.: Hyperlipoproteinämien bei ambulanten Patienten. Dtsch. Med. Wschr. 98, 463 (1973)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fuhrmann, W. (1976). Diabetes Mellitus and Hyperlipidemias. In: Creutzfeldt, W., Köbberling, J., Neel, J.V. (eds) The Genetics of Diabetes Mellitus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66332-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-66332-1_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-07651-3
Online ISBN: 978-3-642-66332-1
eBook Packages: Springer Book Archive